Clinical and Translational Science Institute
临床与转化科学研究所
基本信息
- 批准号:10484419
- 负责人:
- 金额:$ 2.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-18 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvanced DevelopmentAreaAwardCaliforniaClinical ResearchClinical SciencesCollaborationsCommunicationCommunitiesConfusionCore GrantDataDevelopmentEffectivenessEnsureEnvironmentEvaluationFosteringFoundationsFundingHealthHealth Care ResearchHeterogeneityInformaticsInfrastructureInstitutesLeadLeadershipLongevityMethodsMissionNational Center for Advancing Translational SciencesParentsPositioning AttributeProcessProgram EvaluationRecording of previous eventsResearchResourcesSan FranciscoStandardizationTrainingTranslational ResearchUniversitiesVisionWorkWorkforce DevelopmentWorkloadimprovedinnovationmeetingsmembermultimodalitytoolworking group
项目摘要
ABSTRACT
The UCSF Clinical and Translational Science Institute (CTSI) has a long history of excellence in program
evaluation and quality improvement. Since its first round of funding in 2006, UCSF CTSI has been a national
leader in transforming the clinical and translational research community through the development,
demonstration, and dissemination of innovative tools and resources. In this proposal, we aim to expand efforts
to address the need for more standardized and streamlined interactions between UCSF CTSI, CLIC, national
CTSA hubs, and NCATS through the development of an “NCATS QA/QC administrative liaison” position
focused on the following three specific aims. Aim 1: To manage and improve the quality of UCSF CTSI-
related administrative submissions to NCATS. Aim 2: To participate in CTSA consortium-wide QA/QC
activities and propose innovations through creating an intermural infrastructure and sharing of best
practices. Aim 3: To strengthen UCSF CTSI's evaluation and continuous quality improvement efforts.
We envision the NCATS QA/QC administrative liaison position successfully achieving the above three aims
over the course of our five-year parent award and enabling the realization of UCSF CTSI's UL1 aims. This
position will fill a critical need for UCSF CTSI and for the larger CTSA consortium, advancing the development,
demonstration, and dissemination of high-impact QA/QC innovations that ensure effective and efficient
administrative partnership between NCATS and the CTSA hubs.
摘要
加州大学旧金山分校临床和翻译科学研究所(CTSI)在项目方面有着悠久的卓越历史
评估和质量改进。自2006年第一轮融资以来,加州大学旧金山分校的CTSI一直是全国性的
通过开发实现临床和转化型研究社区转型的领导者,
示范和传播创新工具和资源。在这项建议中,我们的目标是扩大努力
为了满足加州大学旧金山分校CTSI、CLIC、National
CTSA中心和NCATS通过设立“NCATS QA/QC行政联络”职位
重点关注以下三个具体目标。目标1:管理和提高UCSF CTSI的质量-
向NCATS提交相关行政意见书。目标2:参与CTSA联盟范围内的QA/QC
通过创建校际基础设施和共享最佳方案来开展活动并提出创新建议
练习。目标3:加强UCSF CTSI的评估和持续质量改进工作。
我们预计NCATS QA/QC行政联络职位将成功实现上述三个目标
在我们的五年家长奖的过程中,并使UCSF CTSI的UL1目标得以实现。这
该职位将满足加州大学旧金山分校CTSI和更大的CTSA财团的迫切需求,推动开发,
示范和传播高影响力的QA/QC创新,确保有效和高效
NCATS和CTSA中心之间的行政伙伴关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kirsten Bibbins-Domingo其他文献
Kirsten Bibbins-Domingo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kirsten Bibbins-Domingo', 18)}}的其他基金
Enhancing Resident Investigation and Career Advancement in Cardiovascular and Pulmonary Science
加强心血管和肺科学领域的住院医师调查和职业发展
- 批准号:
10201732 - 财政年份:2018
- 资助金额:
$ 2.01万 - 项目类别:
UCSF Career Development Program in Implementation Research in Heart and Lung Diseases
加州大学旧金山分校心肺疾病实施研究职业发展计划
- 批准号:
9372145 - 财政年份:2017
- 资助金额:
$ 2.01万 - 项目类别:
UCSF Career Development Program in Implementation Research in Heart and Lung Diseases
加州大学旧金山分校心肺疾病实施研究职业发展计划
- 批准号:
10197202 - 财政年份:2017
- 资助金额:
$ 2.01万 - 项目类别:
Assessing Patient and Community Engagement in Data Governance
评估患者和社区对数据治理的参与
- 批准号:
10592230 - 财政年份:2016
- 资助金额:
$ 2.01万 - 项目类别:
SF BUILD: Enabling full representation in science
SF BUILD:实现科学领域的全面代表性
- 批准号:
10201644 - 财政年份:2014
- 资助金额:
$ 2.01万 - 项目类别:
UCSF Research in Implementation Science for Equity (RISE-2)
加州大学旧金山分校公平实施科学研究 (RISE-2)
- 批准号:
9899292 - 财政年份:2014
- 资助金额:
$ 2.01万 - 项目类别:
Hypertension Management in Minority and Low-income Populations
少数民族和低收入人群的高血压管理
- 批准号:
9132783 - 财政年份:2014
- 资助金额:
$ 2.01万 - 项目类别:
SF BUILD: Enabling full representation in science
SF BUILD:实现科学领域的全面代表性
- 批准号:
9974526 - 财政年份:2014
- 资助金额:
$ 2.01万 - 项目类别:
SF BUILD: Enabling full representation in science
SF BUILD:实现科学领域的全面代表性
- 批准号:
10197156 - 财政年份:2014
- 资助金额:
$ 2.01万 - 项目类别:
相似海外基金
ADVANCED DEVELOPMENT OF LQ A LIPOSOME-BASED SAPONIN-CONTAINING ADJUVANT FOR USE IN PANSARBECOVIRUS VACCINES
用于 Pansarbecovirus 疫苗的 LQ A 脂质体含皂苷佐剂的先进开发
- 批准号:
10935820 - 财政年份:2023
- 资助金额:
$ 2.01万 - 项目类别:
ADVANCED DEVELOPMENT OF BBT-059 AS A RADIATION MEDICAL COUNTERMEASURE FOR DOSING UP TO 48H POST EXPOSURE"
BBT-059 的先进开发,作为辐射医学对策,可在暴露后 48 小时内进行给药”
- 批准号:
10932514 - 财政年份:2023
- 资助金额:
$ 2.01万 - 项目类别:
Advanced Development of a Combined Shigella-ETEC Vaccine
志贺氏菌-ETEC 联合疫苗的先进开发
- 批准号:
10704845 - 财政年份:2023
- 资助金额:
$ 2.01万 - 项目类别:
Advanced development of composite gene delivery and CAR engineering systems
复合基因递送和CAR工程系统的先进开发
- 批准号:
10709085 - 财政年份:2023
- 资助金额:
$ 2.01万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10409385 - 财政年份:2022
- 资助金额:
$ 2.01万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10710595 - 财政年份:2022
- 资助金额:
$ 2.01万 - 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
- 批准号:
10630975 - 财政年份:2022
- 资助金额:
$ 2.01万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION
金黄色葡萄球菌感染候选疫苗的高级开发
- 批准号:
10710588 - 财政年份:2022
- 资助金额:
$ 2.01万 - 项目类别:
ADVANCED DEVELOPMENT OF A VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES
针对大流行和突发冠状病毒的疫苗的高级开发
- 批准号:
10788051 - 财政年份:2022
- 资助金额:
$ 2.01万 - 项目类别: